Tag Archives: PATIENTS

Lilly’s Cyramza (ramucirumab) Becomes First FDA-Approved Biomarker-Driven Therapy in Patients with Hepatocellular Carcinoma

Print this page INDIANAPOLIS, May 13, 2019 /PRNewswire/ — Eli Lilly and Company (NYSE: LLY) today announced that the U.S. Food and Drug Administration (FDA) has approved Cyramza (ramucirumab injection, 10 mg/mL solution), as a single agent, for the treatment of patients with hepatocellular carcinoma (HCC) who have an alpha-fetoprotein (AFP) of ≥400 ng/mL and… Read More »

Researchers warn about gangrene cases in patients on SGLT2 diabetes drugs

After the FDA last year slapped a warning label on SGLT2 diabetes drugs, detailing risks of an infection with a rare flesh-eating bacteria, a team of researchers has come out with a new set of numbers—and a warning for doctors prescribing the drugs. In a study published in the Annals of Internal Medicine, researchers found… Read More »

No Differences in Cortical Measures in Patients With and Without Headache – Neurology Advisor

There are no significant differences in cerebral cortex measurements between patients with and without headache, according to a study published in Pain. In this large, population-based study, investigators analyzed data from the Nord-Trøndelag Health Surveys on participants aged 50 to 66 years, with and without headache, who were selected from the general population (N=1006). Participants… Read More »